MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Researchers first recognized antimony-119 (Sb-119) more than two decades ago as a potentially promising radioactive isotope ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...